Literature DB >> 17592910

Provider and patient characteristics associated with antidepressant nonadherence: the impact of provider specialty.

Kara Zivin Bambauer1, Stephen B Soumerai, Alyce S Adams, Fang Zhang, Dennis Ross-Degnan.   

Abstract

OBJECTIVE: Given the widespread use of anti-depressants in primary care and specialty populations, we sought to examine whether provider specialty and patient demographic and clinical characteristics were associated with nonadherence to antidepressant therapy.
METHOD: We conducted an observational cohort study of 11,878 patients enrolled in Harvard Pilgrim Health Care who were newly treated with antidepressants between May 2002 and May 2004. Using generalized estimating equations, we examined predictors of 2 types of anti-depressant nonadherence: (1) immediate non-adherence: never refilling an antidepressant prescription; and (2) 6-month nonadherence: refilling an antidepressant prescription at least once, but not satisfactorily completing a 6-month treatment episode.
RESULTS: Compared with patients treated by primary care physicians (PCP), being treated by a psychiatrist was associated with significantly lower odds of immediate nonadherence (PCP 18% vs. psychiatrist 13%). Being treated by another type of specialist was associated with significantly higher odds of both immediate (other specialist 23%) and 6-month nonadherence (PCP 53%, psychiatrist 49%, other specialist 62%). Treatment by multiple providers was associated with lower odds of nonadherence than being treated by only 1 provider. Younger patient age and use of pain medication were associated with greater nonadherence.
CONCLUSION: Rates of both immediate and 6-month nonadherence are high, and clinicians should emphasize the importance of continuing antidepressant treatment for a sufficient duration. Patients whose depression treatment is initiated by nonpsychiatric specialists may benefit from collaborative care models. These strategies may enable providers to better manage the long-term disability associated with their patients' depression.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17592910     DOI: 10.4088/jcp.v68n0607

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  16 in total

1.  Coverage of atypical antipsychotics among medicare drug plans in the state of washington: changes between 2007 and 2008.

Authors:  Meng-Yun Wu; Jae Kennedy; Lawrence J Cohen; Chi-Chuan Wang
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2009

2.  Predicting persistence to antidepressant treatment in administrative claims data: Considering the influence of refill delays and prior persistence on other medications.

Authors:  Greta A Bushnell; Til Stürmer; Alice White; Virginia Pate; Sonja A Swanson; Deborah Azrael; Matthew Miller
Journal:  J Affect Disord       Date:  2016-02-09       Impact factor: 4.839

3.  Antidepressant adherence: are patients taking their medications?

Authors:  Randy A Sansone; Lori A Sansone
Journal:  Innov Clin Neurosci       Date:  2012-05

4.  Antidepressant adherence after psychiatric hospitalization among VA patients with depression.

Authors:  Kara Zivin; Dara Ganoczy; Paul N Pfeiffer; Erin M Miller; Marcia Valenstein
Journal:  Adm Policy Ment Health       Date:  2009-07-16

Review 5.  Patient preference for psychological vs pharmacologic treatment of psychiatric disorders: a meta-analytic review.

Authors:  R Kathryn McHugh; Sarah W Whitton; Andrew D Peckham; Jeffrey A Welge; Michael W Otto
Journal:  J Clin Psychiatry       Date:  2013-06       Impact factor: 4.384

Review 6.  Agomelatine in the treatment of major depressive disorder: potential for clinical effectiveness.

Authors:  Sidney H Kennedy; Sakina J Rizvi
Journal:  CNS Drugs       Date:  2010-06       Impact factor: 5.749

7.  Vicarious experience affects patients' treatment preferences for depression.

Authors:  Seth A Berkowitz; Robert A Bell; Richard L Kravitz; Mitchell D Feldman
Journal:  PLoS One       Date:  2012-02-21       Impact factor: 3.240

8.  Does change in cognitive function predict change in costs of care for people with a schizophrenia diagnosis following cognitive remediation therapy?

Authors:  Clare Reeder; Victoria Harris; Andrew Pickles; Anita Patel; Matteo Cella; Til Wykes
Journal:  Schizophr Bull       Date:  2014-03-28       Impact factor: 9.306

9.  Factors influencing adherence to psychopharmacological medications in psychiatric patients: a structural equation modeling approach.

Authors:  Carlos De Las Cuevas; Jose de Leon; Wenceslao Peñate; Moisés Betancort
Journal:  Patient Prefer Adherence       Date:  2017-03-28       Impact factor: 2.711

10.  Regimen complexity and medication nonadherence in elderly patients.

Authors:  Andrea Corsonello; Claudio Pedone; Fabrizia Lattanzio; Maria Lucchetti; Sabrina Garasto; Claudia Carbone; Cosetta Greco; Paolo Fabbietti; Raffaele Antonelli Incalzi
Journal:  Ther Clin Risk Manag       Date:  2009-03-26       Impact factor: 2.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.